FilingReader Intelligence

Fosun Pharma completes RMB1bn bond issuance

August 9, 2025 at 05:09 AM UTC•By FilingReader AI

Shanghai Fosun Pharmaceutical Group completed its second science and technology innovation bond issuance for 2025, raising RMB1 billion at 2.70% interest, maturing August 2027.

The company also issued guarantees totaling approximately RMB2.39 billion for subsidiaries, including RMB1.08 billion for Fosun Antgene and smaller amounts for various Jianjia subsidiaries and Meizhong Huli.

This report was generated by FilingReader's AI system from regulatory filings and company disclosures. To request a correction, contact editorial@filingreader.com

Primary Source Document

Fosun Pharma H share announcement - date of board meetingAugust 8, 2025 at 08:00 AM UTC

Supplementary Source Documents

Fosun Pharma's announcement on the completion of the issuance of the second tranche of 2025 science and technology innovation bondsAugust 8, 2025 at 08:00 AM UTC

Fosun Pharma's Announcement on the Progress of Providing Guarantees for its Controlling SubsidiariesAugust 8, 2025 at 08:00 AM UTC

Shanghai Fosun Pharmaceutical Group

SSE:600196•Shanghai Stock Exchange

PharmaceuticalsShanghai Blue Chip

RSS feed for Shanghai Fosun Pharmaceutical Group

News Alerts

Get instant email alerts when Shanghai Fosun Pharmaceutical Group publishes news

Free account required • Unsubscribe anytime

Browse RSS Feeds

Filing Activity Timeline

View Complete Filing History →